Stellina Study for Diazepam Nasal Spray (Valtoco)

A Clinical Trial for 2 to 5 Year Old Children With Epilepsy

LGS is tough. Finding information shouldn’t be. That is why we provide information about clinical trials in LGS. We hope you find this information useful as you navigate your LGS journey.

The Stellina Study is a Phase 1/2a clinical study evaluating a single dose of diazepam nasal spray (VALTOCO) as a rescue medication in children aged 2-5 who have been diagnosed with epilepsy. The objectives of the study are to assess the pharmacokinetics (PK) of diazepam after one intranasal dose of VALTOCO as well as assess the long-term safety and tolerability in the six-month open-label safety period.

Additional Information:

View the Stellina Study Brochure

Visit the Stellina Study Clinical Webpage 

The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. The content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options.

Updated: 2/20/23